Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Intrepid Capital’s Top Small-Cap Stocks: Tetra Tech Inc. (TTEK), Bio-Rad Laboratories Inc. (BIO), Ingram Micro Inc. (IM), Telephone & Data Systems Inc. (TDS)

Page 1 of 2

Intrepid Capital Management, led by Mark Travis, has disclosed its equity portfolio in a new 13F filing with the U.S. Securities and Exchange Commission for the reporting period as of the end of the first quarter of 2015. Florida-based Intrepid Capital Management is a mid-sized value fund that was founded in 1994. The fund’s equity portfolio is comprised of 41 positions valued at about $327.8 million as of the reporting period. The fund is mainly focused on information technology, finance and healthcare companies. In this article, we will talk about Intrepid Capital’s top small-cap stocks: Tetra Tech Inc. (NASDAQ:TTEK), Bio-Rad Laboratories Inc. (NYSE:BIO), Ingram Micro Inc. (NYSE:IM), and Telephone & Data Systems Inc. (NYSE:TDS).


We track hedge funds to determine their top small-cap stock picks, which according to our research, have historically managed to generate alpha even though the filings are delayed up to a maximum of 45 days. As part of our backtesting, we used a 60-day delay to be on the safe side, and our research showed that the 15 most popular small-cap stocks among hedge funds still outperformed the S&P 500 Total Return Index by an average of 95 basis points per month between 1999 and 2012. After adjusting for risk, our calculations revealed that these stocks’ monthly alpha was 80 basis points. We have been sharing and tracking the performance of these stocks since the end of August 2012 and they have returned 141% over the last 32 months, outperforming the S&P 500 ETF by over 80 percentage points (see more details here).

The top small-cap holding of Intrepid is in Tetra Tech Inc. (NASDAQ:TTEK), a $1.6-billion market cap provider of consulting, engineering, program management, and construction management services. Intrepid Capital trimmed its stake in the company by about 6% to 1.16 million shares worth $27.8 million. Last month, Tetra Tech Inc. (NASDAQ:TTEK) reported a 14% increase in its quarterly dividend to $0.08 per share, bumping its yield to 1.21%. In addition, the company recently signed an agreement to acquire Cornerstone Environmental Group, an environmental engineering and consulting firm focusing on solid waste markets in the United States. Centaur Capital Partners, led by Zeke Ashton, held 141,100 Tetra Tech Inc. (NASDAQ:TTEK) shares at the end of 2014.

Intrepid Capital cut its position in Bio-Rad Laboratories Inc. (NYSE:BIO) by over 40% during the first quarter. The fund disclosed owning 151,861 shares, down from 265,349 shares held previously. At the time of reporting, the value of the stake was $20.53 million. Bio-Rad Laboratories Inc. (NYSE:BIO) is a $4.2-billion provider of life science research and clinical diagnostic products. The company’s net income for the first quarter of 2015 increased to $17.8 million or $0.61 per share, from $6.7 million or $0.23 per share in the same period last year. However, revenues of $472.8 million were down by 7.2% from $509.3 million year-over-year. Among the largest shareholders of Bio-Rad Laboratories Inc. (NYSE:BIO) is John W. Rogers’ Ariel Investments, which held 1.14 million shares worth $154.3 million at the end of the first quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!